Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical gabapentin for pruritus in epidermolysis bullosa
IRCT20210822052258N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of gabapentin in epidermolysis bullosa (EB) and pruritus, sponsored by Shiraz University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
gabapentin
03
Conditions
epidermolysis bullosa (EB)pruritus
Beyond the preview
Go deeper on IRCT20210822052258N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210822052258N1.